secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001638833-25-000031
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q4 revenue up 17.5% to $864.4M; Adj EBITDA +15.1%; sets 2025 guidance
--------------------------------------------------------------------------------

- Q4 revenue $864.4M (+17.5% YoY); full-year revenue $3.1B (+13.5% YoY).
- Q4 adjusted EBITDA $163.8M (+15.1%); full-year $508.2M (+16.0%).
- Same-facility revenue growth 5.6% in Q4, 8.0% full year; cases +5.1% and +3.9% respectively.
- Net loss attributable $108.5M Q4, $168.1M full year; includes non-cash tax valuation allowance. No federal income taxes expected until 2029.
- 2025 guidance: revenue $3.30-$3.45B; Adj EBITDA $555-$565M. Liquidity >$770M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000031/0001638833-25-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883325000031/sgry-20250303.htm
  HTML page:      https://secwatch.observer/filing/0001638833-25-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer